Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization (MYRROR)


June 1, 2015

Clinical trial

Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization: The MYRROR Study.

Ikuno Y, Ohno-Matsui K, Wong TY, Korobelnik JF, Vitti R, Li T, Stemper B, Asmus F, Zeitz O, Ishibashi.

Ophthalmology. 2015 Jun;122(6):1220-7.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive